Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 6Head & Neck 3Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 2Sarcoma 1Plasma cell 1Breast 1

Conditions

Leukemia 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma 76Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Non-Hodgkin 58Lymphoma, Follicular 58Lymphoma, Large B-Cell, Diffuse 56Burkitt Lymphoma 56Lymphoma, Large-Cell, Immunoblastic 50Myelodysplastic Syndromes 49Leukemia, Myeloid, Acute 47Lymphoma, Mantle-Cell 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 44Hodgkin Disease 39Leukemia, Myeloid, Accelerated Phase 36Multiple Myeloma 31Neoplasms, Plasma Cell 30Dendritic Cell Sarcoma, Interdigitating 30Congenital Abnormalities 29Myeloproliferative Disorders 27Leukemia, Myelomonocytic, Chronic 25Blast Crisis 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Myelodysplastic-Myeloproliferative Diseases 21Graft vs Host Disease 21Anemia, Refractory, with Excess of Blasts 21Recurrence 20Waldenstrom Macroglobulinemia 15Sezary Syndrome 15

Interventions

Cytarabine 4Cyclophosphamide 4Amifostine 4Etoposide 3sargramostim 2Voriconazole 2Radiotherapy 2Methotrexate 2pegaspargase 1glucarpidase 1Vincristine 1Silymarin 1Pyridostigmine Bromide 1Prednisolone 1Phenobarbital 1Mitoxantrone 1Methylprednisolone 1Mercaptopurine 1Leucovorin 1Irinotecan 1Ifosfamide 1Idarubicin 1Hydrocortisone 1Filgrastim 1Fibroblast Growth Factor 7 1Epoetin Alfa 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Deoxycytidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Radiotherapy × Other hematologic neoplasm × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡